Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Antidote Articles

Antidote: Chantix

July 15, 2011

One out of five Americans still smokes, and smoking leads to cancer and heart disease.
 

Antidote: simvastatin

June 15, 2011

The problem with a media-megaphoned report about a drug's potential side effect is that it too easily balloons into a fear-driven avoidance of a life-saving group of drugs.
 

Antidote: Vicodin

May 13, 2011

A recent survey from IMS Health reveals that Vicodin is the most frequently prescribed painkiller in the US, with 131 million prescriptions written over the past year alone.
 

Antidote: generic drugs

April 15, 2011

Use of generic drugs has grown dramatically in the US, to the point where currently almost 75% of the drugs we use are generic.
 

Antidote: potassium iodide

March 15, 2011

Potassium iodide is a useful medication. It is also poorly understood, and has functioned as a "fear pill" in the current climate of radiation worries.
 

Antidote: influenza

February 15, 2011

Influenza, like all viruses, has a simple structure. A package of genetic material (in this case RNA), is covered by a protein envelope.
 

Antidote: new cancer detection test

January 14, 2011

Johnson & Johnson has received a lot of criticism lately because of the McNeil recalls of cold medicines, especially those for children. Factories must follow protocols which include sterility and proper oversights.
 

Antidote: aspirin

December 15, 2010

Good old aspirin, therapeutic compound derived from willow bark, take a well-deserved bow. Well-publicized cases of aspirin induced bleeding are not the topic du jour.
 

Antidote: Coumadin

November 15, 2010

I and every other clinician who treats patients with the common blood thinner warfarin (Coumadin) have a problem.
 

Antidote: cancer treatments

October 15, 2010

There is an ongoing revolution occurring in the treatment of cancer. Unfortunately, it is easy for the public to miss the growing excitement for the new targeted therapies and vaccines because of the typical news media fascination with bad news rather than good.
 
« Previous
Next »
  

Web Exclusive

What NOT to say to an MS Patient

Dorothy Wetzel June 07, 2013

It is often hard to find the right words when talking to a patient, friend or family member with MS. Even with training and awareness of the disease, we often blurt out something we think is innocuous only to find out later that we have deeply offended. The Health Activists that Extrovertic spoke to had some suggestions for having positive conversations with someone with MS.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Accountable Care Organizations Acquisition Adherence Advertising App Cardiovascular Clinical Trial Diabetes FDA Generic Generic Drugs Health Affairs Healthcare Reform Journal Articles Layoffs Mobile Obesity Oncology OPDP Patent Cliff Patents Research & Development Rheumatology Social Media Women's Health

Topics

Consumer
Continuing Medical Education (CME)
Digital
Direct to Consumer
Direct to Patient
Downsize
Education & Awareness
FDA
Label
Legal
Online
Over the Counter
Promotion
Public Relations
Sales Force
Trend

Sectors

Agency
Biotech
Government
Media
Pharmaceutical
Suppliers & Vendors

Verticals

Business
Marketing & Communications
Regulatory
Research & Development

Events

Awards

Archives

Issue Archive
Sitemap
 

© 2013 Haymarket Media, Inc.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization.

Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions